BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20392234)

  • 1. Insights into the pathogenesis of Paget's disease.
    Roodman GD
    Ann N Y Acad Sci; 2010 Mar; 1192():176-80. PubMed ID: 20392234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62(P392L) mutation to Paget's disease.
    Kurihara N; Hiruma Y; Yamana K; Michou L; Rousseau C; Morissette J; Galson DL; Teramachi J; Zhou H; Dempster DW; Windle JJ; Brown JP; Roodman GD
    Cell Metab; 2011 Jan; 13(1):23-34. PubMed ID: 21195346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of bone.
    Teramachi J; Zhou H; Subler MA; Kitagawa Y; Galson DL; Dempster DW; Windle JJ; Kurihara N; Roodman GD
    J Bone Miner Res; 2014 Jun; 29(6):1456-65. PubMed ID: 24339057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of measles virus nucleocapsid protein in osteoclasts induces Paget's disease-like bone lesions in mice.
    Kurihara N; Zhou H; Reddy SV; Garcia Palacios V; Subler MA; Dempster DW; Windle JJ; Roodman GD
    J Bone Miner Res; 2006 Mar; 21(3):446-55. PubMed ID: 16491293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment.
    Hiruma Y; Kurihara N; Subler MA; Zhou H; Boykin CS; Zhang H; Ishizuka S; Dempster DW; Roodman GD; Windle JJ
    Hum Mol Genet; 2008 Dec; 17(23):3708-19. PubMed ID: 18765443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles virus nucleocapsid protein increases osteoblast differentiation in Paget's disease.
    Teramachi J; Nagata Y; Mohammad K; Inagaki Y; Ohata Y; Guise T; Michou L; Brown JP; Windle JJ; Kurihara N; Roodman GD
    J Clin Invest; 2016 Mar; 126(3):1012-22. PubMed ID: 26878170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental models of Paget's disease.
    Kurihara N; Zhou H; Reddy SV; Garcia Palacios V; Subler MA; Dempster DW; Windle JJ; Roodman GD
    J Bone Miner Res; 2006 Dec; 21 Suppl 2():P55-7. PubMed ID: 17229020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype.
    Rea SL; Walsh JP; Ward L; Yip K; Ward BK; Kent GN; Steer JH; Xu J; Ratajczak T
    J Bone Miner Res; 2006 Jul; 21(7):1136-45. PubMed ID: 16813535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoclast inhibitory peptide-1 (OIP-1) inhibits measles virus nucleocapsid protein stimulated osteoclast formation/activity.
    Shanmugarajan S; Youssef RF; Pati P; Ries WL; Rao DS; Reddy SV
    J Cell Biochem; 2008 Jul; 104(4):1500-8. PubMed ID: 18348201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease.
    Kurihara N; Hiruma Y; Zhou H; Subler MA; Dempster DW; Singer FR; Reddy SV; Gruber HE; Windle JJ; Roodman GD
    J Clin Invest; 2007 Jan; 117(1):133-42. PubMed ID: 17187080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased S1P expression in osteoclasts enhances bone formation in an animal model of Paget's disease.
    Nagata Y; Miyagawa K; Ohata Y; Petrusca DN; Pagnotti GM; Mohammad KS; Guise TA; Windle JJ; David Roodman G; Kurihara N
    J Cell Biochem; 2021 Apr; 122(3-4):335-348. PubMed ID: 33107091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoclast-derived IGF1 is required for pagetic lesion formation in vivo.
    Miyagawa K; Ohata Y; Delgado-Calle J; Teramachi J; Zhou H; Dempster DD; Subler MA; Windle JJ; Chirgwin JM; Roodman GD; Kurihara N
    JCI Insight; 2020 Mar; 5(6):. PubMed ID: 32078587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etiology of Paget's disease and osteoclast abnormalities.
    Reddy SV
    J Cell Biochem; 2004 Nov; 93(4):688-96. PubMed ID: 15389972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's Disease.
    Kurihara N; Reddy SV; Araki N; Ishizuka S; Ozono K; Cornish J; Cundy T; Singer FR; Roodman GD
    J Bone Miner Res; 2004 Jul; 19(7):1154-64. PubMed ID: 15176999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NFAM1 signaling enhances osteoclast formation and bone resorption activity in Paget's disease of bone.
    Sambandam Y; Sundaram K; Saigusa T; Balasubramanian S; Reddy SV
    Bone; 2017 Aug; 101():236-244. PubMed ID: 28506889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profile in osteoclasts from patients with Paget's disease of bone.
    Michou L; Chamoux E; Couture J; Morissette J; Brown JP; Roux S
    Bone; 2010 Mar; 46(3):598-603. PubMed ID: 19925894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of ATF7-TAF12 interactions in the vitamin D response hypersensitivity of osteoclast precursors in Paget's disease.
    Teramachi J; Hiruma Y; Ishizuka S; Ishizuka H; Brown JP; Michou L; Cao H; Galson DL; Subler MA; Zhou H; Dempster DW; Windle JJ; Roodman GD; Kurihara N
    J Bone Miner Res; 2013 Jun; 28(6):1489-500. PubMed ID: 23426901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of Paget's disease of bone.
    Ralston SH
    Bone; 2008 Nov; 43(5):819-25. PubMed ID: 18672105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoclasts formed by measles virus-infected osteoclast precursors from hCD46 transgenic mice express characteristics of pagetic osteoclasts.
    Reddy SV; Kurihara N; Menaa C; Landucci G; Forthal D; Koop BA; Windle JJ; Roodman GD
    Endocrinology; 2001 Jul; 142(7):2898-905. PubMed ID: 11416009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiologic factors in Paget's disease of bone.
    Reddy SV
    Cell Mol Life Sci; 2006 Feb; 63(4):391-8. PubMed ID: 16429324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.